{"id":323770,"date":"2026-10-22T12:41:59","date_gmt":"2026-10-22T07:11:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=323770"},"modified":"2026-10-22T12:41:59","modified_gmt":"2026-10-22T07:11:59","slug":"ingredients-and-custom-manufacturing-oral-solid-generics-and-large-branded-generics-stocks-roadmap-harbinger-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/ingredients-and-custom-manufacturing-oral-solid-generics-and-large-branded-generics-stocks-roadmap-harbinger-list\/","title":{"rendered":"3 Ingredients and Custom Manufacturing, Oral Solid Generics and Large Branded Generics Stocks With a Strong Future Roadmap: Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories"},"content":{"rendered":"

Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories: ROE of 11.1% to 19.4% and FY22 to FY26 revenue CAGR of 11.8% to 21.1%. Prices as of 21 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three pharma ingredient and generic formulation stocks to watch are Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories. Their return on equity ranges from 11.1% to 19.4%, and their revenue compound annual growth from FY22 to FY26 ranges from 11.8% to 21.1%. Neuland Laboratories leads on both return on equity at 19.4% and revenue growth at 21.1% a year. Prices are based on the 21 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

Pharma ingredient and generic formulation stocks let investors follow companies that make the building blocks of medicines and the finished products themselves. Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories cover ingredients and custom manufacturing, oral solid generics and large branded generics.<\/p>\n

This list covers three pharma ingredient and generic formulation stocks with complete current figures: Neuland Laboratories, Strides Pharma Science and Dr. Reddy’s Laboratories. Every figure comes from the latest reported financials and the 21 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n